Veeva Systems (NYSE:VEEV – Get Free Report) updated its first quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.740-1.750 for the period, compared to the consensus estimate of 1.620. The company issued revenue guidance of $726.0 million-$729.0 million, compared to the consensus revenue estimate of $725.8 million. Veeva Systems also updated its FY 2026 guidance to 7.320-7.320 EPS.
Wall Street Analyst Weigh In
Several research firms have weighed in on VEEV. Mizuho initiated coverage on shares of Veeva Systems in a research note on Wednesday, December 4th. They set an “outperform” rating and a $275.00 target price for the company. Evercore ISI boosted their price objective on shares of Veeva Systems from $220.00 to $245.00 and gave the company an “in-line” rating in a research report on Friday, December 6th. KeyCorp dropped their price objective on shares of Veeva Systems from $285.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. Stifel Nicolaus lifted their target price on Veeva Systems from $240.00 to $272.00 and gave the company a “buy” rating in a research note on Friday, December 6th. Finally, Scotiabank upped their price objective on Veeva Systems from $235.00 to $240.00 and gave the stock a “sector perform” rating in a research note on Friday, December 6th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $254.80.
Check Out Our Latest Stock Analysis on VEEV
Veeva Systems Price Performance
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Oversold Stocks With Major Reasons to Rebound
- Investing in Construction Stocks
- Robinhood’s Rally: Is Global Expansion the Next Big Catalyst?
- Market Cap Calculator: How to Calculate Market Cap
- Eli Lilly Pours $27B Into U.S. Growth—What It Means for Investors
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.